Early 20th century

Early 20th century is the period in which medical optimism about opioids collided with mounting evidence of dependence and a turn toward prohibition. The book uses this history to show that opioid addiction was not always understood chiefly as a criminal or inner-city problem: doctors had helped create some cases, heroin was once widely sold as medicine, and public warnings had been issued well before the later prescription crisis. Its significance lies in the cycle it exposes—promotion, belated alarm, restriction, and forgetting—and in the unequal consequences of how addiction was subsequently classified.

Medical Use and Early Warnings

By the turn of the century, opioid-derived medicines were already widely used, and addiction was not confined to one social group. The historical account describes doctors, working people, and household users whose habits could remain difficult to see while their supply was steady. In 1895, addressing the New York Academy of Medicine, a Brooklyn physician criticized colleagues who left morphine and syringes with patients and advised them to use the drug whenever they felt pain. He warned that dependence could develop after only three or four doses and argued that some cases could have been prevented if physicians had not prescribed morphine in the first place. By 1900, more than 250,000 Americans were addicted to opium-derived painkillers.

Heroin’s early commercial life stood in sharp contrast to those warnings. Medical journals praised Bayer’s product as a cough suppressant, and some presented it as superior to morphine or as a replacement for it. Researchers had begun to note that the drug’s risks were not fully known, but for eight years heroin remained available at American drugstores and by mail order. The American Medical Association issued a stronger warning in 1906, stating that the habit formed readily and led to grave consequences. Admissions related to heroin rose in hospitals in New York and Philadelphia during the 1910s and 1920s, as officials recognized addiction among injured patients as well as recreational users. A condition once associated with soldiers was described by New York City’s health commissioner as having become a national disease.

Restriction and Social Reclassification

The Harrison Narcotics Act of 1914 sharply restricted the sale and possession of heroin and other narcotic drugs. In 1924, manufacture of heroin was outlawed, twenty-six years after Bayer’s product entered the market. The legal change did not simply end medical use; it altered the circumstances in which dependent people obtained drugs and how society described them. By the 1930s, the typical heroin user was increasingly characterized as working-class, often a child of immigrants, or a member of a group such as jazz musicians. Users depended on criminal networks to obtain drugs and avoid withdrawal.

The social meaning of addiction shifted with that change. Earlier users who had become dependent through medical treatment, including people in small towns, receded from public memory. The remaining users were increasingly labeled as criminals rather than patients. The book stresses that this was not a neutral change in vocabulary: the image of the addicted person narrowed, while the earlier visibility of doctor-associated dependence was lost. The history therefore links drug control not only to the regulation of a substance but also to the changing social category assigned to those who used it.

Warnings That Faded from View

Contemporary newspapers had documented the breadth of opioid exposure in ordinary life. A 1914 account condemned infant remedies that contained narcotic ingredients while being advertised as harmless to babies. Elsewhere on the same page, a Richmond physician advertised an opium treatment institution and promised a cure within ten days to three weeks. The juxtaposition captures a period in which warnings and commercial claims could appear side by side, without resolving the underlying problem of dependence or establishing a durable public understanding of it.

The book treats these reports as evidence of historical amnesia: the warnings did not remain active guides to later policy and practice. Once they receded from living memory, the same underlying confidence in medical prescribing could return under new conditions. The early history is thus more than background chronology. It establishes that opioid dependence, physician involvement, and commercially promoted claims of safety had all appeared before, even as later generations came to regard a new epidemic as unforeseen.

The Later Echo in Pain Medicine

The account draws a careful parallel with the late twentieth-century prescription-opioid wave rather than treating the eras as identical. Purdue Pharma promoted OxyContin by repeating a low estimate of addiction risk and presenting opioid prescribing as responsible care. In 1996, the drug’s introduction coincided with the spread of pain as the fifth vital sign. Hospitals and accreditation bodies adopted stronger pain-assessment standards, and patient satisfaction measures created pressure to relieve reported pain. In 1999, the Joint Commission on Accreditation of Healthcare Organizations approved mandatory standards for pain assessment and treatment.

Purdue’s own planning documents show how the new standards could become a commercial opportunity. The company described the accreditation requirements as a chance to establish itself as a leader in pain management and budgeted for branded pens, binders, charts, and clipboards. At the same time, the apparent precision of pain scales concealed important limits: a subjective score could be standardized without reliably measuring an objective condition, and reliance on such scales did not necessarily improve outcomes. The account connects these practices to increased opioid prescribing and abuse, while noting that physicians later recognized the consequences of prescribing with insufficient understanding of risk.

The historical pattern is therefore one of recurrence without exact repetition. Early medical confidence, commercial availability, and warnings that failed to reshape practice offer a precedent for the later expansion of prescription opioids. The gap between the two periods is itself part of the argument: knowledge can exist in records and still fail to govern future decisions when its warnings lose force, its affected people are recategorized, and new systems make medication appear both measurable and medically necessary.